Results 141 to 150 of about 16,659 (195)

Renal Function and Cardiovascular Risk: An Overlooked Prognostic Ally. [PDF]

Arq Bras Cardiol
Soares GP, Salim TR.
europepmc   +1 more source

DOSAGEM DE CREATININA SÉRICA EM AMOSTRAS LIPÊMICAS E HEMOLISADAS

ENCICLOPÉDIA BIOSFERA
Ana Melo, Daniel Scapin, Eduarda Santos, Falcão Black, Fernanda Cripa, Mayara Stumm, Luciana Machado   +6 more
openaire   +1 more source

Renal outcomes in the long-term follow-up of lupus nephritis. [PDF]

J Bras Nefrol
Polycarpo SB, Kirsztajn GM.
europepmc   +1 more source

Serum and urinary biomarkers in lupus nephritis: do suPAR and VEGF play a role? [PDF]

J Bras Nefrol
Piraciaba TT, Riguetti MTP, Kirsztajn GM.   +2 more
europepmc   +1 more source

[Pharmacokinetic interaction between linezolid and rifampicin: A case report]. [PDF]

Rev Esp Quimioter
Fernández-Vázquez A, Ayala-Álvarez-Canal J, García González D, Sáez-Villafañe M, Dios-Díez P, Ortiz-de-Urbina-González JJ.   +5 more
europepmc   +1 more source

The role of cystatin C in kidney injury in children and adolescents with type 1 diabetes mellitus: a systematic review. [PDF]

J Bras Nefrol
Gkiourtzis N, Stoimeni A, Michou P, Moutafi M, Cheirakis K, Christakopoulos A, Glava A, Panagopoulou P, Tsigaras G, Galli-Tsinopoulou A, Christoforidis A, Tramma D.   +11 more
europepmc   +1 more source

Elevated circulating fibroblast growth factor 23 is associated with acute kidney injury and mortality in coronavirus disease 2019 (COVID-19). [PDF]

J Bras Nefrol
Narayanan G, Campos MO, Groninger N, Burney HN, Hays M, Dollins M, Arroyo E, Halim A, Li Y, Sher SJ, Moe S, Lim K.   +11 more
europepmc   +1 more source

Patients with chronic kidney disease stage 3b: do general practitioners and nephrologists follow KDIGO guidelines? [PDF]

J Bras Nefrol
Macedo JG, Almeida AM, Sanders-Pinheiro H, Fabreti-Oliveira RA.   +3 more
europepmc   +1 more source

Prevention is less expensive than treatment in chronic kidney disease: a descriptive analysis. [PDF]

J Bras Nefrol
Alcalde PR, Fernandes DE, Kirsztajn GM.
europepmc   +1 more source

KIM-1 as a biomarker of kidney tubular damage in normoalbuminuric patients with type 2 diabetes mellitus and insulin resistance. [PDF]

J Bras Nefrol
Oliveira LE, Paniz C, Moresco RN, Carvalho JAM.   +3 more
europepmc   +1 more source